memo - Magazine of European Medical Oncology 3/2008

nach oben

Inhaltsverzeichnis ( 13 Artikel )

01.09.2008 | Commentary | Ausgabe 3/2008

Approaching personalized cancer medicine

G. Gastl

01.09.2008 | CECOG News | Ausgabe 3/2008

CECOG at ASCO 2008

Dagmar Just

01.09.2008 | Review | Ausgabe 3/2008

Proteomics, a new tool to monitor cancer therapy?

J. Loeffler-Ragg, B. Sarg, D. Mueller, T. Auer, H. Lindner, H. Zwierzina

01.09.2008 | Short review | Ausgabe 3/2008

Personalized medicine – p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer

D. Kandioler

01.09.2008 | Short review | Ausgabe 3/2008

Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?

A. Eniu

01.09.2008 | Case report | Ausgabe 3/2008

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

K. Prassl, A. Sahanic, B. Reicher, H. Denz, M. Freund, M. Fiegl

01.09.2008 | Case report | Ausgabe 3/2008

Ocular abnormality as the first sign of metastatic breast cancer: the presentation of two cases

Z. Kahán, Á. Szabó, A. Cserháti

01.09.2008 | Congress report | Ausgabe 3/2008

"Old tricks and new procedures" – a report from the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation EBMT, March 30 – April 2, 2008, Florence, Italy

E. Willenbacher, W. Willenbacher

01.09.2008 | Review | Ausgabe 3/2008

Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

A. Tzankov

01.09.2008 | Short review | Ausgabe 3/2008

Treatment options in localised and metastatic renal cell carcinoma

A. P. Berger, A. Hobisch

01.09.2008 | Review article | Ausgabe 3/2008

Individualized molecular cancer therapy based on radiolabelled somatostatin analogues

M. Gabriel, U. Andergassen, I. J. Virgolini

01.09.2008 | Short review | Ausgabe 3/2008

Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

G. Fritsche, G. Weiss

01.09.2008 | Announcement | Ausgabe 3/2008

memo - Magazine of European Medical Oncology

Ausgabe 3/2008

Inhaltsverzeichnis ( 13 Artikel )

Approaching personalized cancer medicine

CECOG at ASCO 2008

Proteomics, a new tool to monitor cancer therapy?

Personalized medicine – p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer

Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

Ocular abnormality as the first sign of metastatic breast cancer: the presentation of two cases

"Old tricks and new procedures" – a report from the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation EBMT, March 30 – April 2, 2008, Florence, Italy

Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

Treatment options in localised and metastatic renal cell carcinoma

Individualized molecular cancer therapy based on radiolabelled somatostatin analogues

Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

Announcement

Ausgabe 2/2020

Ausgabe 1/2020

Sonderheft 2/2020

Sonderheft 1/2020

Sonderheft 4/2019

Ausgabe 4/2019

Ausgabe 3/2019

Sonderheft 3/2019

Sonderheft 2/2019

Ausgabe 2/2019

Springer Medizin Österreich

Inhaltsverzeichnis ( 13 Artikel )

Approaching personalized cancer medicine

CECOG at ASCO 2008

Proteomics, a new tool to monitor cancer therapy?

Personalized medicine – p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer

Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

Ocular abnormality as the first sign of metastatic breast cancer: the presentation of two cases

"Old tricks and new procedures" – a report from the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation EBMT, March 30 – April 2, 2008, Florence, Italy

Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

Treatment options in localised and metastatic renal cell carcinoma

Individualized molecular cancer therapy based on radiolabelled somatostatin analogues

Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

Announcement

Aktuelle Ausgaben

Ausgabe 2/2020

Ausgabe 1/2020

Sonderheft 2/2020

Sonderheft 1/2020

Sonderheft 4/2019

Ausgabe 4/2019

Ausgabe 3/2019

Sonderheft 3/2019

Sonderheft 2/2019

Ausgabe 2/2019